SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-129786
Filing Date
2014-04-03
Accepted
2014-04-03 16:17:05
Documents
17
Period of Report
2014-05-15
Effectiveness Date
2014-04-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A d640773ddef14a.htm DEF 14A 1351675
2 GRAPHIC g640773amgen_letterhead.jpg GRAPHIC 6327
3 GRAPHIC g640773david_scott.jpg GRAPHIC 8476
4 GRAPHIC g640773g01a01.jpg GRAPHIC 14967
5 GRAPHIC g640773g27n33.jpg GRAPHIC 13908
6 GRAPHIC g640773g37l44.jpg GRAPHIC 1962
7 GRAPHIC g640773g63w38.jpg GRAPHIC 7798
8 GRAPHIC g640773g69o07.jpg GRAPHIC 11272
9 GRAPHIC g640773g87b32.jpg GRAPHIC 16196
10 GRAPHIC g640773ima1.jpg GRAPHIC 160460
11 GRAPHIC g640773ima2.jpg GRAPHIC 208536
12 GRAPHIC g640773ima3.jpg GRAPHIC 184582
13 GRAPHIC g640773letterhead_002.jpg GRAPHIC 11009
14 GRAPHIC g640773recycle_symbol.jpg GRAPHIC 2556
15 GRAPHIC g679294g34b46.jpg GRAPHIC 5477
16 GRAPHIC g679294g34u02.jpg GRAPHIC 3050
17 GRAPHIC g679294g73k25.jpg GRAPHIC 5555
  Complete submission text file 0001193125-14-129786.txt   2267500
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-12477 | Film No.: 14742383
SIC: 2836 Biological Products, (No Diagnostic Substances)